clinical trial · NCT07396844
The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers
LG Chem·phase1·not yet recruiting·n = 28
HealthyFastingFedFixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg
brief summary
This is a single dose, randomized, open-label, two-way crossover study to investigate the food-effect bioavailability of the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg in healthy volunteers under fasting and fed conditions.
started
Jul 1, 2026
primary completion
Jul 31, 2026
completion
Jul 31, 2026
last updated
Apr 13, 2026
official title
A Single Dose, Randomized, Open-label, Two-way Crossover Food-effect Bioavailbility Study of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg Sustained Release Tablets Under Fasting and Fed Conditions in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol